GlobeNewswire

Magnitude Software Acquires SAP Business Analytics Innovator Every Angle

Dela

Acquisition Strengthens Magnitude's Position in SAP Ecosystem with Self-Service SAP Analytics and Reporting; Expands Presence in Europe

AUSTIN, Texas, June 27, 2018 (GLOBE NEWSWIRE) -- Magnitude Software, Inc., a leader in delivering unified application data management to global organizations across industries, today announced the acquisition of Every Angle Software Solutions, a provider that enables users of SAP-run organizations to optimize their operational performance by empowering insightful and flexible business analytics. Every Angle's self-service solution works on any SAP system (ECC and HANA) and hides the complexity of SAP's data structure, allowing end users to quickly identify and resolve key business issues. This third acquisition in the past eight months, and seventh in total, immediately expands Magnitude's leadership presence in the SAP ecosystem alongside providing a mature base of operations in Europe.

"Magnitude's mission is to simplify the complex application landscape for our customers and help them realize significant productivity gains by unlocking the value promised by enterprise platforms like SAP," said Chris Ney, Chairman and CEO of Magnitude Software. "Every Angle shares a similar mission - delivering superior data access and analysis to uncover operational insights and efficiencies, which makes it an ideal complement to Magnitude's Unified Application Data Management product family."

The largest global ERP provider with 23% market share according to Gartner, SAP represents a significant market opportunity for the combined solutions of Magnitude and Every Angle. SAP's Data 2020: State of Big Datareport highlighted the need for better enterprise data management, including the ability to unify application data. The joint Magnitude-Every Angle portfolio addresses that need directly by empowering users to gain insights as well as identify and resolve key business issues, while hiding the complexity of SAP's data structure.

Every Angle Software Solutions complement Magnitude's expansive SAP Application Data Management solution set, which includes agile SAP data management from Innowera, and SAP Central Finance integration through Magnitude SourceConnect. In addition to having access to these products, Every Angle customers can leverage the full portfolio of Magnitude's Unified Application Data Management solutions, designed to harness the fragmented digital landscape for business benefit through simplified data access, management, analytics and reporting. This portfolio includes Magnitude Master Data Management (MDM), Agility Product Information Management (PIM), and Magnitude Simba connectivity solutions.

"We are excited about joining Magnitude as it will provide both companies the opportunity to accelerate global expansion, while offering SAP customers an unmatched unified application data management portfolio including an agile analytics suite," said Fred Hermans, CEO of Every Angle. "We share a vision of simplifying the access to and analysis of data from ERP systems that will allow our customers to increase the business value they realize with these systems."

Both companies employ customer-centric models and will aim to leverage their combined expertise to broaden their collective value proposition to customers worldwide.

Fred Hermans will continue to lead the business within Magnitude as SVP, Every Angle Solutions, driving the Every Angle solution vision while cementing Every Angle's role within the broader Magnitude vision, mission and portfolio. Every Angle customers can expect to work with their same support and consulting services teams with an opportunity to leverage the expertise and products of Magnitude Software.

For more information, please read the Acquisition FAQ and blog post.

About Every Angle
Every Angle is an international software company that empowers users of SAP-run organizations to know more and act faster in their operational responsibilities contributing to continuous business improvement. The software's embedded, cross-functional intelligence transforms Supply Chain, Human Resource, GRC and Finance data into actionable business insight. The plug-and-play solution works on any SAP system (ECC and HANA) and will remove the need for time consuming and expensive BI design and development projects. Every Angle's solution hides the complexity of SAP's data structure and empowers business users to operate within a culture based on prevention rather than cure. The self-service analytics model allows users to identify and resolve key business issues before the customer even notices, and frees IT resources and funds to focus on more strategic initiatives. www.everyangle.com

About Magnitude Software
Magnitude's transformative approach to unified application data management delivers vast operational efficiencies to business application data access, management, analytics and reporting for the modern enterprise. Magnitude's portfolio of products includes: simplified application data access to any data source; data management solutions for the SAP and commerce verticals; simplified master data harmonization and governance; and packaged application analytics and reporting solutions for SAP and Oracle. The company helps thousands of business users simplify management of their data and deliver on the substantial productivity gains these applications originally promised. For more information, please visit www.magnitude.com

For more information, press only:
Lauren Johnson
Scratch Marketing + Media
Lauren@scratchmm.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Magnitude Software via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Arcoma presenterar på Redeye Life Science Day den 21:a november16.11.2018 12:53Pressmeddelande

16 November Den 21 november presenterar Jesper Söderqvist, VD på Arcoma, den senaste utvecklingen i Arcoma på Haymarket by Scandic i Stockholm. Presentationen "Arcoma, ett tillväxtbolag i en växande marknad" hålls klockan 13:00 och kan följas i livesändning på redeye.se/live/lsday-2018. Presentationen kommer även i efterhand att finnas tillgänglig på www.redeye.se/live/ls-day-2018 samt på Bolagets sida i Redeye Universe (redeye.se/company/Arcoma) Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalitet och avancerad teknik. Arcomas produkter erbjuder den senaste digitala bildtekniken kombinerat med tekniskt avancerade rörliga positioneringssystem, vilket tillsammans med ergonomisk skandinavisk design, erbjuder kunden kompletta, konfigurerbara och funktionella digitala röntgensystem. Bolagets produkter säljs via återförsäljare samt via OEM-kunder och det finns idag över 3 500 av Arcomas röntgensystem installerade

Iconovo: kundprojekt blir framflyttat tre till sex månader8.11.2018 15:45Pressmeddelande

Fortsatt arbete med ett av Iconovos pågående kundprojekt kommer att flyttas fram tre till sex månader. Projektet avser utveckling av produkt anpassad för kund som ska svara för produktion och marknadslansering. Det aktuella arbetet var planerat att ske under fjärde kvartalet men beräknas ske under nästa år, och detta påverkar Iconovos omsättning under 2018 negativt med cirka 2 miljoner kronor. Orsaken är att kunden har beslutat att genomföra en mindre klinisk studie för att verifiera produkten innan nästa steg tas vilken omfattar investeringar i betydande mångmiljonbelopp i produktionskapacitet, baserat på Iconovos utveckling. Studien görs för kundens egna räkning och är inte villkorad av tillsynsmyndigheter. "Detta påverkar vårt resultat på kort sikt, men det faktum att kunden har beslutat att göra en betydande investering i faktisk produktion betyder att vi med stor säkerhet kan se fram emot licensintäkter under en lång tidsrymd framöver i samband med att produkten lanseras på markna

Stillfront Group AB: Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 20187.11.2018 14:34Pressmeddelande

PRESSMEDDELANDE 7 november 2018 Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 2018 Stillfront Groups kvartalsrapport för det tredje kvartalet 2018 kommer att publiceras klockan 07.00 den 22 november 2018. En webbsänd telefonkonferens kommer att hållas klockan 10.00 samma dag där Jörgen Larsson, VD och Sten Wranne, CFO, kommenterar resultatet. Presentationen och rapporten kommer efter presentationen att finnas tillgänglig på www.stillfront.com Webbsändningen nås på adressen: https://tv.streamfabriken.com/stillfront-q3-2018 För att delta via telefon, vänligen ring: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FÖR YTTERLIGARE INFORMATION, VÄNLIGEN KONTAKTA: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com OM STILLFRONT Stillfront är en oberoende utvecklare, förläggare och distributör av digitala spel - med visionen att bli en ledande indie-spelutvecklare och förläggare. Stillfront är verksamt genom tio näst intill självständiga dotte

Stillfront Group AB: Invitation to Stillfront Group Q3 presentation7.11.2018 14:34Pressmeddelande

Invitation to Stillfront Group Q3 presentation Stillfront Group interim report for the third quarter 2018 will be published at 07.00 CET on 22 November 2018. A presentation of the report will be held the same day at 10.00 CET via telephone conference or audiocast where Jörgen Larsson, CEO and CFO Sten Wranne are to comment on the report. The presentation can be viewed live at https://tv.streamfabriken.com/stillfront-q3-2018 To participate via phone please call: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FOR FURTHER INFORMATION, PLEASE CONTACT: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com ABOUT STILLFRONT Stillfront is a group of independent creators, publishers and distributors of digital games - with a vision to become the leading group of indie game creators and publishers. Stillfront operates through ten near-autonomous subsidiaries: Bytro Labs in Germany, Coldwood Interactive in Sweden, Power Challenge in the UK and Sweden, Dorado Online Games

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum